Key Points
- Healthpeak EVP Ankit Patadia sold 6,115 shares for about $127,070, reducing his stake by 68.3% to 2,838 shares.
- The REIT’s latest quarter showed mixed results: EPS of $0.02 missed the $0.43 consensus estimate, while revenue rose 16.3% year over year to $820.9 million and exceeded forecasts.
- Healthpeak announced a monthly dividend of $0.1017 per share, equivalent to $1.22 annually and a 5.9% yield. Analysts’ consensus rating is Hold, with an average price target of $21.47.
Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) EVP Ankit Patadia sold 6,115 shares of the firm's stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $20.78, for a total transaction of $127,069.70. Following the sale, the executive vice president owned 2,838 shares in the company, valued at $58,973.64. This trade represents a 68.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Healthpeak Properties Stock Performance
Shares of DOC opened at $20.67 on Tuesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.02 and a current ratio of 1.29. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95. The firm's 50 day moving average price is $19.74 and its two-hundred day moving average price is $19.21. The firm has a market cap of $14.25 billion, a P/E ratio of 11.08, a PEG ratio of 2.49 and a beta of 1.01.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.41). Healthpeak Properties had a net margin of 12.32% and a return on equity of 4.04%. The company had revenue of $820.89 million during the quarter, compared to analyst estimates of $739.18 million. During the same quarter last year, the company earned $0.46 EPS. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. On average, analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 18th will be given a $0.1017 dividend. This represents a $1.22 annualized dividend and a yield of 5.9%. The ex-dividend date of this dividend is Friday, December 18th. Healthpeak Properties's payout ratio is currently 225.93%.
Analyst Ratings Changes
A number of brokerages recently weighed in on DOC. Barclays reduced their target price on shares of Healthpeak Properties from $24.00 to $21.00 and set an "equal weight" rating for the company in a research note on Tuesday, October 13th. Jefferies Financial Group began coverage on Healthpeak Properties in a research note on Tuesday, September 15th. They issued a "hold" rating and a $21.00 price target on the stock. Royal Bank Of Canada lifted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Saturday. Finally, UBS Group cut their price target on Healthpeak Properties from $21.50 to $20.00 and set a "neutral" rating on the stock in a report on Tuesday, October 13th. Four research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $21.47.
Check Out Our Latest Analysis on Healthpeak Properties
Hedge Funds Weigh In On Healthpeak Properties
Several hedge funds have recently made changes to their positions in the business. State Street Corp raised its holdings in shares of Healthpeak Properties by 92.3% in the second quarter. State Street Corp now owns 93,267,685 shares of the real estate investment trust's stock valued at $1,995,928,000 after purchasing an additional 44,767,085 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Healthpeak Properties by 60.3% during the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock worth $253,949,000 after purchasing an additional 5,815,189 shares during the last quarter. Bank of America Corp DE acquired a new position in Healthpeak Properties during the second quarter worth $234,600,000. Dimensional Fund Advisors LP boosted its holdings in Healthpeak Properties by 2.8% during the first quarter. Dimensional Fund Advisors LP now owns 10,583,736 shares of the real estate investment trust's stock worth $173,896,000 after purchasing an additional 290,589 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in Healthpeak Properties by 83.4% in the second quarter. Envestnet Asset Management Inc. now owns 7,761,469 shares of the real estate investment trust's stock valued at $166,095,000 after purchasing an additional 3,530,429 shares in the last quarter. 93.57% of the stock is owned by institutional investors.
About Healthpeak Properties
(
Get Free Report)
Healthpeak Properties, Inc is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities.
The company's properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.
Based in Denver, Colorado, Healthpeak traces its history to a healthcare property company founded in 1985.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
